The Human SLE Syndrome Systemic lupus erythematosus (SLE) was first considered a multiphenotypic disease syndrome by Moritz Kaposi of Vienna in 1872 (1) . At the beginning of this century SLE was already believed to be, at least in part, an immune disorder on the basis of observations of false-positive syphilis serology in some patients. SLE is the prorotypic autoimmune disease, characterized by a large variety of autoantibodies and a wide range of clinical manifestations and diverse organ involvement. Once thought of as a rare and invariably fatal disease, improved diagnosis shows that 1:1000 women may be at risk to develop certain SLE symptoms during their lifetime (2) . SLE is predominantly a disease ofw*nen of chilbearing age. It is estimated that in the United States alone 400,000 to 1,000,000 suffer from various forms of SLE. Clinical manifestations range from transient skin lesions or polyarthritis to renal failure (3, 4) . This wide spectrum of clinical pictures, and thus phenotypes, presents difficulties in early diagnosis and treatment and harnessing modern genetic analysis to search for susceptibility loci and candidate genes. Genome mapping depends on high penetrance of an unequivocal phenotype, i.e., the full expression in most individuals with the same genotype. This is a problem with the varied clinical features of SLE; furthermore, SLE may not be a single disease entity.
It was recognized early that SLE is a great mimic of other diseases such as syphilis, rheumatoid arthritis, hemolytic anemia, and tuberculosis. Additionally, it was proposed that there are genetic as well as environmental components that contribute to this disease (1, 5) . Exposure to ultraviolet (UV) radiation, infection, diet, therapeutic drugs, physical and mental stress, and hormonal status (pregnancy) can have profound effects on the immune system and thus may contribute to the pathogenesis of SLE (3) (4) (5) . Family and ethnic studies and investigations of identical twins strongly suggest a genetic basis for this syndrome as well as for the influence of the environment on genetic susceptibility. Because of the wide range of the SLE phenotype penetrance, it has been impossible to resolve whether the environmental influences on this disease initiate pathogenesis or enhance the penetrance of a low-grade, previously unrecognized phenotype.
The pathogenesis and etiology of SLE are only partially understood, but the hallmark is an inappropriate immune response to several autoantigens, particularly native DNA, chromatin, nucleoproteins, nucleosomes, histones, phospholipids, myeloperoxidase, thyroglobulin, and many other subcellular organelles (6) .
The autoimmune response in SLE does not appear to be an indiscriminate polyclonal activation of silent clones but several specific antigen-driven responses, each under separate genetic control. This implies that environmental effects may also act in a specific fashion. It is noteworthy that in SLE and diabetes mouse models, evidence is accumulating that each of these autoimmune humoral responses is influenced or directed by separate and diverse non-major histocompatability complex (MHC) loci (discussed later). These autoimmune responses per se may not be pathogenic. The formation of DNA-anti-DNA autoantibody complexes in the circulation or in situ, the generation of organ-or tissue-specific cytotoxic T cells, and the generation of inflammatory cascades and the release of cytokines combine to cause severe chronic or acute illness. These pathogenic immune reactivities are modulated by neurologic and endocrine functions. Thus such as interleukins to modulate the autoimmune responses (see "Effects of Environment on Murine SLE").
We propose (using a new mouse model of SLE) that an environmental influence on SLE may not be observable in individuals with the full complement of SLE genes, but that individuals with a number of susceptibility loci below a certain threshold level will respond to such an insult. Thus, an effect may be more readily observed in a moderately lupus-prone strain rather than in strains with already extremely high disease penetrance. This is apparent in some patients with transient SLE symptoms when they have an adverse reaction to a drug such as procainamide (7) . Thus, it may be a cumulative insult on the immune system that triggers SLE in individuals with a partial genotype. This may also account for the unusual discordance of SLE in some sets of identical twins in that the partial genotype results in environmentally dependent phenotypic expression, whereas the full genotype alone is sufficient for disease in both identical individuals (8) .
Genetic analyses of the murine SLE models provide support for the emerging concept that SLE susceptibility involves a complex interaction between SLE disease-specific as well as pleiotropic autoimmune genes. Such complexities make the genetic analysis of heterozygous families and ethnic groups difficult until loci and candidate genes are mapped in an appropriate mouse model such as the female NZB x NZWF1 (BWF1) (9) . The genetic and phenotypic diversity of the NZM (New Zealand mixed) recombinant inbred mouse strains (10, 11) and the congenic strains derived from them (12) (13) (14) (15) (16) 
Nephritis Phenotypes
The renal disease phenotype of the NZM strains varies by time course and penetrance (10) . As shown in Figure 1 Figure 2 ). Immune complex deposits in the skin (19) and hypertension phenotypes have not been determined (20) . Glomerular lesions progress from infiltration by neutrophils to accumulations of mononuclear cells with concomitant mesangial matrix expansion and cellular proliferation. The mice succumb with florid crescentic glomerulonephritis or diffuse end-stage glomerulosclerosis ( Figure 3A-C Kier (21) . The phenotype is present in some of the NZM strains ( Figure  4A-D) . This phenotype segregates independently from nephritis ( Figure 5 ) and is also variably penetrant (Figure 6) Figure 4B ). (Tables 3-5) (11, 16) . Extensive genetic studies were done to map SLE loci using NZM 2410 with highly penetrant renal disease in both sexes. Wakeland and colleagues (11) (12) (13) (14) (15) (16) 30) Vyse and Kotzin (28) ]. Some of these susceptibility loci (named Sk, Lbw, Sbw, Nba) are summarized in Table 4 along with their phenotype expressions. Several other NZ recendy mapped non-MHC loci contribute to the control of autoantibody formation to DNA, nucleoproteins, myeloperoxidase, and thyroglobulin (16) . Previously, murine SLE in BWF1 hybrids was thought to be controlled by one or two dominant loci derived from the MHC region of each parent (28 (11, 16, 28) . hLocus designation, approximate location in centimorgans (cM). on several chromosomes, the apparent involvement of complementation, and epistasis genes make the genetic analysis of SLE unexpectedly difficult even in an inbred mouse system. At present there are more than a dozen loci that map with varying degrees of statistical confidence to 15 of the 19 autosomal chromosomes [reviewed in Vyse and Kotzin (28) ]. This list is expected to grow considerably.
Although NZM 2410 mice are being phenotyped and mapped in ever greater detail (11) (12) (13) (14) (15) (16) 30) , the genetic makeup of the other NZM strains remains tentative. Table 5 summarizes a hypothetical view of the distribution of some of the mapped and proposed loci deduced from several nearby known polymorphisms such as coat color genes on chromosomes 2, 4, and 7 (agouti, brown, pink-eyeddilute, and albino, respectively). Skel of NZW on chromosome 1 appears to be present in all NZM strains. The NZB loci may be absent. Chromosome 2 is recombinant only in NZM 64 (C5+/nonagouti); this provides a possible protective (C5-sufficient) locus (27) . On chromosome 4, the close linkage of SIe2 with b (brown) of NZW shows that the two pinkeyed-dilute/brown (tan) strains (2410 and 391) contain this locus; however, 2410 also has most probably the additional NZB loci Nbal, Lbw2, and Sbw2. Chromosome 7 is recombinant and retained p (pink-eyed-dilute) and lost c (albino). This fortuitous mixing of the NZB/NZW genome on chromosome 7 suggests that all these mapped loci (Table 5) are present in all six strains, particularly SIe3 that is closely linked to p. The all-important MHC SLE loci are only partially, but uniformly, present in the NZM strains. All are homozygous for the NZW H2 complex (K", Iu, SZ, D!), which implies that the direct or epistatic effects of SIe4ILbwl (heterozygosity at HZ) are absent in all strains. The mechanism by which this heterozyotic element imparts its influence on renal disease is unknown. However, the possible predisposing loci, C4 (10) and tumor necrosis factor (TF)-at (34) deficiencies, are present in all NZM strains. Thus, this hypothetical as well as established genetic diversity ofthe strains may provide further important information. Table 5 suggests that genetic differences on chromosomes 2 and 4 could be responsible for the substantial penetrance differences among the six NZM strains.
There is now ample evidence that murine lupus and many of the associated autoimmune phenomena are under polygenic control and that the penetrance, time course, and severity of disease are influenced by a large number of susceptibility loci. It is important to recognize that some of these SLE loci colocalize with autoimmune insulin-dependent diabetes (Id loci of nonobese diabetic (NOD) mice (28, 35) . These findings support the concept that disease-specific loci as well as pleiotropic Environmental Health Perspectives * Vol 107, Supplement 5 * October 1999 autoimmune loci must be considered. These loci interact in various combinations to fit a threshold liability model (Figure 7) (11) . The linkage studies lead to the conclusion that the accumulation of multiple component phenotypes results in the diverse forms of the SLE syndrome. These traits may have to exceed several thresholds for the disease to become overtly manifest. There may also be epistatic loci that suppress or alter the level of expression. It (Tables 6, 7 ) and the curious fact that Pb intoxication of normal mice for more than 1 year does not cause renal lesion or autoimmunity or mortality (40, 41) , it is suggested that without particular and defined genetic backgrounds, Pb does not induce the SLE phenotype or autoimmunity in general.
The effects of Pb on humoral and cellular immunity of rnice have been well characterized, and Pb can be considered an experimental paradigm for environmental influences on the immune system. It is therefore possible that alterations in immunoregulatory mech-anisms (43, 44) . Furthermore, Pb modifies cytokine patterns throughout the body including the central nervous system, a significant partner of the immune and endocrine systems.
Pb modifies the cytokine networks (45) in a fashion similar to that observed in SLE-prone mice (46) , that is, with elevated levels of the T helper (Th)2-promoting cytokines and depressed levels of Th 1-promoting cytokines.
In fact, IL-10 (cytokine synthesis inhibitory factor) is produced by macrophages, B cells, and Th2 cells, and is able to block IL-12 production, which promotes development of Thl cells. It is of interest, therefore, that SLE susceptibility loci Slel and Nba2 on chromosome 1 are near IL-10 and a number of complement proteins and Fc receptor genes (28, 35) . In general, cytokines play a central role in the pathogenesis of human and murine SLE (47) (48) (49) . These observations are supported by the fact that some of the susceptibility loci are closely linked to cytokine genes. Slel is near IL-10 (see above and S1e2 maps near IFN-ar and IFN-3 on chromosome 4 (11) . S/eS is virtually identical with the locus for IL-11 on chromosome 7 (16) . Furthermore, a new locus identified by Morel et al. (16) on chromosome 11 is near a cluster of IL genes for IL-3, 4, 5, and 13. Some of these loci co-localize with susceptibility intervals of the NOD mouse (28, 35) discussed above.
IL-6 positively correlates with active disease (47, 48) , and IL-6 has been reported to promote SLE in BWFI mice (49) . One environmental promoter of SLE is sunlight (UV exposure), which exacerbates SLE (the photosensitivity of SLE ) by enhancing generation in SLE patients (50) . The generation of abnormal amounts of interleukins may contribute to the potentiation of the pathogenic activity displayed by immune complex deposits in the epidermal-dermal junction of sun-exposed skin.
Another well-documented Pb-affected cytokine that enters the SLE equation is TNFa (34) . Here again, murine lupus susceptibility loci in NZM strains (Table 5 ) provide genetic clues: the NZW TNF-a defect maps to H2 (chromosome 17) and Nbal maps near the NZB Tnfr2 (chromosome 4). Some NZM strains may contain these genes (Table 5) .
Recent studies by Fujimura and colleagues (51) 
